Company: EUDAW
Filing Date: 2025-09-24
Form Type: 20-F/A
Source: 0001493152-25-014808
Chunk: 58

Company: EUDA Health Holdings Ltd
Filing Date: 2025-09-24
Form: 20-F/A
Chunk 58
---
 |
| Less: redemption of 8i ordinary shares                           |     |                 | (6,033,455 | ) |
| Conversion of 8i rights                                          |     |                 |    891,725 |   |
| Shares issued to service providers                               |     |                 |    260,000 |   |
| Total shares issued upon the Reverse Recapitalization            |     |                 |  6,191,770 |   |

-Private placements

In May 2023, the Company offered an aggregate of up to 4,000,000ordinary shares of the Company in a private placement.

Between May 16 and May 22, 2023, the Company issued and sold to eight accredited investors an aggregate of 940,000ordinary shares (the “Placement Shares”) at $ 1.00per share for an aggregate to purchase price of $ 940,000in a private placement in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 promulgated thereunder. In July 2023, the Company cancelled 200,000shares as one of the accredited investors did not pay for the shares in a timely manner.

In August 2023, the Company issued and sold to two accredited investors an aggregate of 50,000ordinary shares (the “Placement Shares”) at $ 1.00per share for an aggregate to purchase price of $ 50,000in a private placement in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 promulgated thereunder.

In June 2024, the Company issued and sold to two accredited investors an aggregate of 50,000ordinary shares (the “Placement Shares”) at $ 1.00per share for an aggregate to purchase price of $ 50,000in a private placement in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 promulgated thereunder.

Conversion of debts

-Conversion of debts for the year ended December 31, 2023

On May 16, 2023, the Company signed settlement agreement (“Settlement Agreement”) with James Tan, pursuant to which the Company agreed to issue to James